Analysis of allogeneic versus xenogeneic auxiliary organ perfusion in liver failure reveals superior efficacy of human livers.
OBJECTIVE
To compare the efficacy of allogeneic and xenogeneic extracorporeal liver perfusion (ECLP).


METHODS
An Internet-based keyword search was performed in the established online databases. Univariate and multivariate analysis of variance (general linear method) were performed.


RESULTS
Data from 198 patients were included in the statistical analysis, 142 of whom were treated by ECLP using porcine livers. Baboon livers were used in 29 patients, human livers in 14, and other or mixed species in 13 patients. Pig liver perfusions resulted in a 20% long-term-survival whereas the use of human livers was significantly more successful (survival rate (SVR) 43%, p<0.05). Baboon livers also revealed superior success (41%; p<0.05). Twenty-three patients were treated after 1991, 12 surviving long-term (52%). The latter all belonged to a group of 14 patients who received combined treatment consisting of ECLP and LTx (SVR-86% in this subgroup).


CONCLUSIONS
Allogeneic ECLP was accompanied by significantly improved outcome compared with discordant xenogeneic ECLP. The role of hyperacute rejection in acute liver failure with reduced complement levels remains controversial. Physiologic disparity between pig and man may be the even more decisive determinant of outcome.
Pascher
A
A
andreas.pascher@charite.de
Sauer
I M
IM
Neuhaus
P
P
D000818:Animals; D005112:Extracorporeal Circulation; D006801:Humans; D008102:Liver Circulation; D017114:Liver Failure, Acute / Q000628:therapy*; D019164:Liver, Artificial; D010215:Papio; D010477:Perfusion; D013552:Swine